Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy
Here Are the Major Earnings After the Close Today
Earnings Scheduled For March 3, 2025
Reported Sunday, Roche's Genentech Phase III Study Finds Xolair More Effective And Safer Than Oral Immunotherapy For Food Allergies
Play Defense With Goldman's Cheap Healthcare Picks
Earnings Week Ahead: TGT, COST, CRWD, AVGO, JD, PLUG, MRVL, and More